Regulatory and other responses to the pharmaceutical opioid problem
- PMID: 31389024
- DOI: 10.5694/mja2.50297
Regulatory and other responses to the pharmaceutical opioid problem
Keywords: Analgesics, opioid; Codeine; Pharmacogenomics.
Comment in
-
Regulatory and other responses to the pharmaceutical opioid problem.Med J Aust. 2019 Sep;211(5):237-237.e1. doi: 10.5694/mja2.50303. Epub 2019 Aug 6. Med J Aust. 2019. PMID: 31389014 No abstract available.
Comment on
-
Regulatory and other responses to the pharmaceutical opioid problem.Med J Aust. 2019 Jan;210(1):6-8.e1. doi: 10.5694/mja2.12047. Epub 2018 Dec 12. Med J Aust. 2019. PMID: 30636303 Free PMC article. No abstract available.
References
-
- Campbell G, Lintzeris N, Gisev N, et al. Regulatory and other responses to the pharmaceutical opioid problem. Med J Aust 2019; 210: 6-8. https://www.mja.com.au/journal/2019/210/1/regulatory-and-other-responses...
-
- Royal College of Pathologists of Australia. Position statement: utilisation of pharmacogenetics in healthcare. Sydney: RCPA, 2018. http://www.rcpa.edu.au/Library/College-Policies/Position-Statements/Util... (viewed July 2019).
-
- Crews KR, Gaedigk A, Dunnenberger HM, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther 2014; 95: 376-382.
-
- Gammal RS, Caudle KE, Quinn CT, et al. The case for pharmacogenetics-guided prescribing of codeine in children. Clin Pharmacol Ther 2019; 105: 1300-1302.
-
- van der Wouden CH, Cambon-Thomsen A, Cecchin E, et al. Implementing pharmacogenomics in Europe: design and implementation strategy of the Ubiquitous Pharmacogenomics Consortium. Clin Pharmacol Ther 2017; 101: 341-358.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
